nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—Testosterone—Spironolactone—dilated cardiomyopathy	0.612	1	CrCrCtD
Estramustine—ABCB1—Lisinopril—dilated cardiomyopathy	0.0973	0.532	CbGbCtD
Estramustine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0857	0.468	CbGbCtD
Estramustine—MAP2—LKB1 signaling events—SIK1—dilated cardiomyopathy	0.0161	0.228	CbGpPWpGaD
Estramustine—Glucose tolerance decreased—Furosemide—dilated cardiomyopathy	0.0114	0.148	CcSEcCtD
Estramustine—MAP1A—cardiac ventricle—dilated cardiomyopathy	0.0106	0.184	CbGeAlD
Estramustine—MAP1A—myocardium—dilated cardiomyopathy	0.01	0.173	CbGeAlD
Estramustine—MAP1A—heart—dilated cardiomyopathy	0.00698	0.121	CbGeAlD
Estramustine—MAP2—cardiac ventricle—dilated cardiomyopathy	0.00604	0.105	CbGeAlD
Estramustine—MAP1A—cardiac atrium—dilated cardiomyopathy	0.00597	0.103	CbGeAlD
Estramustine—MAP2—myocardium—dilated cardiomyopathy	0.00568	0.0985	CbGeAlD
Estramustine—MAP2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00562	0.0797	CbGpPWpGaD
Estramustine—MAP2—LKB1 signaling events—PSEN2—dilated cardiomyopathy	0.00513	0.0727	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00434	0.0615	CbGpPWpGaD
Estramustine—MAP2—heart—dilated cardiomyopathy	0.00397	0.0687	CbGeAlD
Estramustine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00386	0.05	CcSEcCtD
Estramustine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00376	0.0487	CcSEcCtD
Estramustine—MAP2—cardiac atrium—dilated cardiomyopathy	0.00339	0.0588	CbGeAlD
Estramustine—ESR1—LKB1 signaling events—SIK1—dilated cardiomyopathy	0.00312	0.0442	CbGpPWpGaD
Estramustine—Lethargy—Spironolactone—dilated cardiomyopathy	0.00311	0.0403	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00309	0.0438	CbGpPWpGaD
Estramustine—ESR2—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00284	0.0402	CbGpPWpGaD
Estramustine—ESR2—heart—dilated cardiomyopathy	0.00257	0.0445	CbGeAlD
Estramustine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00243	0.0314	CcSEcCtD
Estramustine—MAP2—MAPK Cascade—RAF1—dilated cardiomyopathy	0.00234	0.0332	CbGpPWpGaD
Estramustine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.0021	0.0272	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—LAMA4—dilated cardiomyopathy	0.00196	0.0279	CbGpPWpGaD
Estramustine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00192	0.0248	CcSEcCtD
Estramustine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00186	0.0241	CcSEcCtD
Estramustine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00177	0.0229	CcSEcCtD
Estramustine—ESR1—heart—dilated cardiomyopathy	0.00176	0.0305	CbGeAlD
Estramustine—Thirst—Furosemide—dilated cardiomyopathy	0.00174	0.0226	CcSEcCtD
Estramustine—Lethargy—Furosemide—dilated cardiomyopathy	0.00169	0.0219	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00167	0.0237	CbGpPWpGaD
Estramustine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00164	0.0213	CcSEcCtD
Estramustine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00147	0.019	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00143	0.0203	CbGpPWpGaD
Estramustine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00134	0.0174	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.00134	0.019	CbGpPWpGaD
Estramustine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00127	0.0165	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00124	0.016	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00121	0.0171	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00119	0.0169	CbGpPWpGaD
Estramustine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00118	0.0153	CcSEcCtD
Estramustine—ESR1—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.00108	0.0153	CbGpPWpGaD
Estramustine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00107	0.0139	CcSEcCtD
Estramustine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00106	0.0137	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00105	0.0148	CbGpPWpGaD
Estramustine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00103	0.0133	CcSEcCtD
Estramustine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00102	0.0132	CcSEcCtD
Estramustine—ESR1—LKB1 signaling events—PSEN2—dilated cardiomyopathy	0.000997	0.0141	CbGpPWpGaD
Estramustine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000991	0.0128	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000986	0.014	CbGpPWpGaD
Estramustine—Flatulence—Furosemide—dilated cardiomyopathy	0.000985	0.0128	CcSEcCtD
Estramustine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000961	0.0124	CcSEcCtD
Estramustine—Depression—Lisinopril—dilated cardiomyopathy	0.000957	0.0124	CcSEcCtD
Estramustine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000953	0.0123	CcSEcCtD
Estramustine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000946	0.0122	CcSEcCtD
Estramustine—Rash—Spironolactone—dilated cardiomyopathy	0.000945	0.0122	CcSEcCtD
Estramustine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000945	0.0122	CcSEcCtD
Estramustine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000941	0.0122	CcSEcCtD
Estramustine—Headache—Spironolactone—dilated cardiomyopathy	0.000939	0.0122	CcSEcCtD
Estramustine—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00093	0.0132	CbGpPWpGaD
Estramustine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000895	0.0116	CcSEcCtD
Estramustine—Nausea—Spironolactone—dilated cardiomyopathy	0.000891	0.0115	CcSEcCtD
Estramustine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000803	0.0104	CcSEcCtD
Estramustine—Flushing—Lisinopril—dilated cardiomyopathy	0.0008	0.0104	CcSEcCtD
Estramustine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000799	0.0103	CcSEcCtD
Estramustine—Anorexia—Furosemide—dilated cardiomyopathy	0.000778	0.0101	CcSEcCtD
Estramustine—Alopecia—Lisinopril—dilated cardiomyopathy	0.000761	0.00986	CcSEcCtD
Estramustine—Flatulence—Lisinopril—dilated cardiomyopathy	0.000739	0.00957	CcSEcCtD
Estramustine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000721	0.00934	CcSEcCtD
Estramustine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000709	0.00918	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.000697	0.00988	CbGpPWpGaD
Estramustine—ABCB1—heart—dilated cardiomyopathy	0.000696	0.0121	CbGeAlD
Estramustine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000671	0.00869	CcSEcCtD
Estramustine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000638	0.00827	CcSEcCtD
Estramustine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000636	0.00824	CcSEcCtD
Estramustine—Oedema—Lisinopril—dilated cardiomyopathy	0.000612	0.00792	CcSEcCtD
Estramustine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000599	0.00776	CcSEcCtD
Estramustine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000583	0.00755	CcSEcCtD
Estramustine—Pruritus—Furosemide—dilated cardiomyopathy	0.000577	0.00747	CcSEcCtD
Estramustine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000558	0.00723	CcSEcCtD
Estramustine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000554	0.00717	CcSEcCtD
Estramustine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000546	0.00706	CcSEcCtD
Estramustine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000532	0.00689	CcSEcCtD
Estramustine—Vomiting—Furosemide—dilated cardiomyopathy	0.000519	0.00672	CcSEcCtD
Estramustine—Rash—Furosemide—dilated cardiomyopathy	0.000514	0.00666	CcSEcCtD
Estramustine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000514	0.00665	CcSEcCtD
Estramustine—Headache—Furosemide—dilated cardiomyopathy	0.000511	0.00662	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000504	0.00715	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000497	0.00705	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00049	0.00695	CbGpPWpGaD
Estramustine—Nausea—Furosemide—dilated cardiomyopathy	0.000485	0.00627	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000465	0.0066	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.000446	0.00632	CbGpPWpGaD
Estramustine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000433	0.00561	CcSEcCtD
Estramustine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000419	0.00542	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000404	0.00572	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000398	0.00565	CbGpPWpGaD
Estramustine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000389	0.00504	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	0.000386	0.00548	CbGpPWpGaD
Estramustine—Rash—Lisinopril—dilated cardiomyopathy	0.000386	0.005	CcSEcCtD
Estramustine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000386	0.00499	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—RPS6KB1—dilated cardiomyopathy	0.000385	0.00545	CbGpPWpGaD
Estramustine—Headache—Lisinopril—dilated cardiomyopathy	0.000383	0.00496	CcSEcCtD
Estramustine—Nausea—Lisinopril—dilated cardiomyopathy	0.000364	0.00471	CcSEcCtD
Estramustine—ESR1—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000363	0.00515	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000356	0.00504	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	0.000344	0.00487	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	0.000324	0.0046	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—RAC1—dilated cardiomyopathy	0.000321	0.00456	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000319	0.00452	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000315	0.00447	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000308	0.00436	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000308	0.00436	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000302	0.00428	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000263	0.00373	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000247	0.0035	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NR3C2—dilated cardiomyopathy	0.000236	0.00334	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000221	0.00314	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000216	0.00306	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.000213	0.00302	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000206	0.00292	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.0002	0.00284	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000186	0.00263	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000184	0.0026	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000172	0.00245	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000166	0.00236	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000161	0.00228	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	0.000158	0.00224	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000155	0.0022	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000155	0.0022	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000154	0.00218	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000152	0.00216	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NPPA—dilated cardiomyopathy	0.000148	0.0021	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000137	0.00194	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000131	0.00185	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.000121	0.00172	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	0.000119	0.00169	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000107	0.00152	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000104	0.00148	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000104	0.00148	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000101	0.00143	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.71e-05	0.00138	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	8.51e-05	0.00121	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	8.35e-05	0.00118	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	8.3e-05	0.00118	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	8.21e-05	0.00116	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	8.05e-05	0.00114	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	7.47e-05	0.00106	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	7.06e-05	0.001	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	7.06e-05	0.001	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	6.92e-05	0.000981	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	6.64e-05	0.000941	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.59e-05	0.000934	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	6e-05	0.000851	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.34e-05	0.000757	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.7e-05	0.000667	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	4.35e-05	0.000617	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.18e-05	0.000592	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.18e-05	0.000592	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.09e-05	0.00058	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.88e-05	0.00055	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.76e-05	0.000533	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.7e-05	0.000524	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.66e-05	0.000519	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.48e-05	0.000494	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.21e-05	0.000455	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.05e-05	0.000432	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.62e-05	0.000371	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.36e-05	0.000335	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	2.26e-05	0.00032	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.12e-05	0.0003	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.63e-05	0.000231	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.59e-05	0.000225	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.57e-05	0.000222	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.43e-05	0.000203	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.08e-05	0.000152	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1e-05	0.000142	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	9.78e-06	0.000139	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	8.81e-06	0.000125	CbGpPWpGaD
